| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREPARATION | 500 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| EV GLB MACRO ABS RET | 2012-10 | PURCHASE | 2015-01 | 6,000 | 6,161 | -161 | ||||
| ISHS NASDAQ BIOTECH | 2008-12 | PURCHASE | 2015-01 | 1,911 | 402 | 1,509 | ||||
| CONS DSCR SEL SPDR | 2009-06 | PURCHASE | 2015-09 | 993 | 312 | 681 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| EQUITIES | 60,063 | |
| FIXED INCOME | 41,662 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| EQUIBUILDER | AT COST |
| Description | Amount |
|---|---|
| MARKET CHANGES | 12,970 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| INVESTMENT MANAGEMENT FEES | 1,021 | 1,021 | 1,021 | |
| DONATIONS |